SCHEMBL19984711

SCHEMBL19984711

O=C1C=CC(=O)N1C(=O)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX4 Q99571 2/20 0.64
CTRB1 P17538 1/20 0.59
P2RX1 P51575 1/20 0.58
P2RX3 P56373 1/20 0.58
ALDH1A1 P00352 4/20 0.52
KMT2A Q03164 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MAPK1 P28482 2/20 0.50
MEN1 O00255 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PSEN1 P49768 2/20 0.49
PSEN2 P49810 2/20 0.49
APH1B Q8WW43 2/20 0.49
NCSTN Q92542 2/20 0.49
APH1A Q96BI3 2/20 0.49
PSENEN Q9NZ42 2/20 0.49
NPC1 O15118 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL274967 0.81 P2RX4 (0.58) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL5086855 0.81 CTRB1 (0.70) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL8526862 0.78 P2RX4 (0.55) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL19618120 0.78 P2RX4 (0.55) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL22675703 0.78 ALDH1A1 (0.55) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL23298275 0.76 GSK3A (0.57) P2RX4ALDH1A1KMT2AL3MBTL1MAPK1
SCHEMBL4041285 0.76 ALDH1A1 (0.49) P2RX4CTRB1ALDH1A1KMT2AL3MBTL1
SCHEMBL29235094 0.75 NPC1 (0.61) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL22184884 0.74 HTR2C (0.55) P2RX4CTRB1P2RX1P2RX3ALDH1A1
SCHEMBL20673840 0.74 CTRB1 (1.00) P2RX4CTRB1P2RX1P2RX3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023223927-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC株式会社 2023-11-23 WO disclosed
WO-2023279211-A1 METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2023-01-12 WO disclosed
US-11402384-B2 Thermostable glucose biosensors and uses thereof DUKE UNIVERSITY (US) 2022-08-02 US disclosed
CN-112094215-B Method for synthesizing 3-aminopyrrolidine hydrochloride by one-pot method 浙江工业大学 2021-09-24 CN disclosed
CN-112094215-A Method for synthesizing 3-aminopyrrolidine hydrochloride by one-pot method 浙江工业大学 2020-12-18 CN disclosed
WO-2020219287-A1 CAMPTOTHECIN DERIVATIVES IMMUNOGEN, INC. (US) 2020-10-29 WO disclosed
US-20200319194-A1 UREA BIOSENSORS AND USES THEREOF DUKE UNIVERSITY 2020-10-08 US disclosed
US-20200271659-A1 THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF DUKE UNIVERSITY 2020-08-27 US disclosed
EP-2306986-B1 PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES PROLYNX LLC (US) 2018-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200271659-A1 THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF GCKR, G6PD, GCK P2RX4 3586/4885CTRB1 778/4885P2RX1 3292/4885
US-11402384-B2 Thermostable glucose biosensors and uses thereof GCKR, G6PD, GCK P2RX4 3586/4885CTRB1 778/4885P2RX1 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.